MED — Medical/Disease Research/Clinical Labs
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 (PASTEUR Act of 2026), entire bill
Lobbyists: DAN RENBERG; BYRON DORGAN; PHILIP ENGLISH; JON BOUKER; OLIVER SPURGEON III; BLAKE THELANDER; STARSHINE CHUN; KELSEY GRISWOLD-BERGER
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
BUD — Budget/Appropriations
H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill H.R.7148 (Consolidated Appropriations Act, 2026), Division B, Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally Fiscal Year 2027 funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally
Lobbyists: DAN RENBERG; BYRON DORGAN; PHILIP ENGLISH; JON BOUKER; OLIVER SPURGEON III; STARSHINE CHUN; BLAKE THELANDER; KELSEY GRISWOLD-BERGER; BRIAN COEN (covered position: Legislative Aide, Rep. Bonamici (2025 - 2026); Legislative Correspondent and Staff Assistant, Rep. Bonamici (2023 - 2025); Legislative Intern, Rep. Bonamici (2022)) [new]
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/Medicaid
Medicare reimbursement regarding evaluation and management services by infectious disease physicians and practice expense policies
Lobbyists: DAN RENBERG; BYRON DORGAN; PHILIP ENGLISH; JON BOUKER; OLIVER SPURGEON III; BLAKE THELANDER; KELSEY GRISWOLD-BERGER; STARSHINE CHUN
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE